PharmaExcipients China 2019 to Embark on a New Journey!
Laws and regulations of each country have raised higher requirements for pharmaceutical companies and pharmaceutical excipient suppliers in recent years, to ensure the quality and safety of pharmaceutical excipients. The relevant policies for the generic drug quality and efficacy consistency evaluation, information registration of APIs, excipients, and pharmaceutical packaging materials, and related review and approval, etc. introduced in China in recent years have made clear the primary responsibility of the preparation enterprises for the selection of pharmaceutical excipients, which means that excipient enterprises shall be fully subject to the review of preparation enterprises so as to obtain recognition thereof and achieve development and innovation. Driven by the policies, the promotion and application of the new products, new dosage forms, and new processes will bring broad markets for new pharmaceutical excipients.
Implementation of China’s new policy for related review will be a life-or-death test to preparation, pharmaceutical excipient, and pharmaceutical packaging material enterprises, and largely increase requirements for responsibilities and technology of enterprises. Some Chinese enterprises engaging in pharmaceutical excipients and pharmaceutical packaging materials are actively adjusting and reforming to improve product quality and ensure pharmaceutical product quality and safety. And more preparation enterprises have generated urgent needs for quality excipient manufacturers. To further give play to the role of CPhI China as an international exchange platform and serve the generic drug quality and efficacy consistency evaluation by using international advanced ideas and technologies, PharmaExcipients China will embark on a new journey in Hall E3 of Shanghai New International Expo Centre (SNIEC) on June 18-20, 2019 as one of the characteristic segments of CPhI China! The exhibition will set up an international exchange and cooperation platform for the linkage between China’s pharmaceutical excipients and preparation R&D and the organic connection between pharmaceutical product R&D chain and industrial chain, propel enterprises and R&D institutions to strengthen R&D of APIs, excipients, and pharmaceutical packaging materials, promote the lifecycle management, and technological upgrading and innovation of pharmaceutical products, and help enterprises continue to improve pharmaceutical excipient quality.
Gathering Chinese and overseas industry giants, and guiding structure upgrade of excipient enterprises
PharmaExcipients China hosted by CCCMHPIE and UBM EMEA and co-organized by Shanghai UBM Sinoexpo, has gradually become specialized, regulated, and large-scale over the five years accompanying the excipient industry, and has become a platform for the annual gathering, exchange, and close cooperation between practitioners in the Chinese excipient industry and their peers. CPhI China attracted 60,744 visits of visitors from 120 countries and regions during 2018 exhibition; in particular, the visits of overseas visitors showed explosive growth to reach 15,329, growing by over 50% than 2017, most of which were from the main countries that the Chinese excipients are exported to: the U.S., Europe, Japan, Southeast Asia, and India. Numerous exhibitors expanded their booths owing to the good exhibition effects.
As a global leading pharmaceutical excipient supplier, Shanghai Colorcon Coating Technology Co., Ltd. has conducted global cooperation with CPhI. "In the CPhI China this year, Colorcon displayed many new products such as Opadry® QX and Nutrafinish, and brought better choices to customers to help them increase film coating production efficiency and accelerate product marketing; and we also shared with ...
(All Rights Reserved)